» Articles » PMID: 11124951

Polyunsaturated Fatty Acids Suppress Hepatic Sterol Regulatory Element-binding Protein-1 Expression by Accelerating Transcript Decay

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Jan 2
PMID 11124951
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The reduction in hepatic abundance of sterol regulatory element binding protein-1 (SREBP-1) mRNA and protein associated with the ingestion of polyunsaturated fatty acids (PUFA) appears to be largely responsible for the PUFA-dependent inhibition of lipogenic gene transcription. Our initial studies indicated that the induction of SREBP-1 expression by insulin and glucose was blocked by PUFA. Nuclear run-on assays suggested PUFA reduced SREBP-1 mRNA by post-transcriptional mechanisms. In this report we demonstrate that PUFA enhance the decay of both SREBP-1a and -1c. When rat hepatocytes in monolayer culture were treated with albumin-bound 20:4(n-6) or 20:5(n-3) the half-life of total SREBP-1 mRNA was reduced by 50%. Ribonuclease protection assays revealed that the decay of SREBP-1c mRNA was more sensitive to PUFA than was SREBP-1a, i.e. the half-life of SREBP-1c and -1a was reduced from 10.0 to 4.6 h and 11.6 to 7.6 h, respectively. Interestingly, treating the hepatocytes with the translational inhibitor, cycloheximide, prevented the PUFA-dependent decay of SREBP-1. This suggests that SREBP-1 mRNA may need to undergo translation to enter the decay process, or that the decay process requires the synthesis of a rapidly turning over protein. Although the mechanism by which PUFA accelerate SREBP-1 mRNA decay remains to be determined, cloning and sequencing of the 3'-untranslated region for the rat SREBP-1 transcript revealed the presence of an A-U-rich region that is characteristic of a destablizing element.

Citing Articles

Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Rajewski P, Ciescinski J, Rajewski P, Suwala S, Rajewska A, Potasz M Biomedicines. 2025; 13(1).

PMID: 39857800 PMC: 11760440. DOI: 10.3390/biomedicines13010217.


Phosphorylation of Insig-2 mediates inhibition of fatty acid synthesis by polyunsaturated fatty acids.

Tian J, Goldstein J, Li S, Schumacher M, Brown M Proc Natl Acad Sci U S A. 2024; 121(34):e2409262121.

PMID: 39145929 PMC: 11348305. DOI: 10.1073/pnas.2409262121.


Regulation and targeting of SREBP-1 in hepatocellular carcinoma.

Su F, Koeberle A Cancer Metastasis Rev. 2023; 43(2):673-708.

PMID: 38036934 PMC: 11156753. DOI: 10.1007/s10555-023-10156-5.


Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease-Possible Causes and Future Considerations.

Michaeloudes C, Christodoulides S, Christodoulou P, Kyriakou T, Patrikios I, Stephanou A Nutrients. 2023; 15(22).

PMID: 38004225 PMC: 10675410. DOI: 10.3390/nu15224830.


Physiological and pathological roles of lipogenesis.

Jeon Y, Kim Y, Lee G, Kim J Nat Metab. 2023; 5(5):735-759.

PMID: 37142787 DOI: 10.1038/s42255-023-00786-y.